{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T20:45:36Z","timestamp":1767905136876,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T00:00:00Z","timestamp":1630281600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T00:00:00Z","timestamp":1630281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s10096-021-04342-y","type":"journal-article","created":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T18:06:52Z","timestamp":1630346812000},"page":"53-62","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Clinical characteristics, appropriateness of empiric antibiotic therapy, and outcome of Pseudomonas aeruginosa bacteremia across multiple community hospitals"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5029-8755","authenticated-orcid":false,"given":"Keith","family":"Teelucksingh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,30]]},"reference":[{"key":"4342_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/599376","volume":"49","author":"L Mermel","year":"2009","unstructured":"Mermel L, Allon M, Bouza E, Craven D, Flynn P, O\u2019Grady N et al (2009) Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 49:1\u201345. https:\/\/doi.org\/10.1086\/599376","journal-title":"Clin Infect Dis"},{"issue":"5","key":"4342_CR2","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/cid\/ciw353","volume":"63","author":"A Kalil","year":"2016","unstructured":"Kalil A, Metersky M, Klompas M, Muscedere J, Sweeney D, Palmer L et al (2016) Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis 63(5):575\u2013582. https:\/\/doi.org\/10.1093\/cid\/ciw353","journal-title":"Clin Infect Dis"},{"issue":"3","key":"4342_CR3","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/CCM.0000000000002255","volume":"45","author":"N Rhodes","year":"2017","unstructured":"Rhodes N, Evans L, Alhazzani W, Levy M, Massimo M, Ferrer R et al (2017) Surviving sepsis campaign: international guidelines for management of sepsis and septic Shock: 2016. Crit Care Med 45(3):486\u2013552. https:\/\/doi.org\/10.1097\/CCM.0000000000002255","journal-title":"Crit Care Med"},{"issue":"7","key":"4342_CR4","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","volume":"200","author":"J Metlay","year":"2019","unstructured":"Metlay J, Waterer G, Long A, Anzueto A, Brozek J, Crothers K et al (2019) Diagnosis and treatment of adults with community-acquired pneumonia an official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med 200(7):e45\u2013e67. https:\/\/doi.org\/10.1164\/rccm.201908-1581ST","journal-title":"Am J Respir Crit Care Med"},{"key":"4342_CR5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/s1201-9712(98)90055-8","volume":"2","author":"Y Siegman-Igra","year":"1998","unstructured":"Siegman-Igra Y, Ravona R, Primerman H, Giladi M (1998) Pseudomonas aeruginosa bacteremia: an analysis of 123 episodes, with particular emphasis on the effect of antibiotic therapy. Int J Infect Dis 2:211\u2013215. https:\/\/doi.org\/10.1016\/s1201-9712(98)90055-8","journal-title":"Int J Infect Dis"},{"key":"4342_CR6","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1086\/377200","volume":"37","author":"C Kang","year":"2003","unstructured":"Kang C, Kim S, Kim H, Park S, Choe Y, Ohet M et al (2003) Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome. Clin Infect Dis 37:745\u2013751","journal-title":"Clin Infect Dis"},{"issue":"2","key":"4342_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2019.11.004","volume":"55","author":"T Babich","year":"2020","unstructured":"Babich T, Naucler P, Valik J, Giske C, Benito N, Cardona R et al (2020) Risk factors for mortality among patients with Pseudomonas aeruginosa bacteraemia: a retrospective multicentre study. Int J Antimicrob Agents 55(2):105847. https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.11.004","journal-title":"Int J Antimicrob Agents"},{"key":"4342_CR8","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1001\/archinte.145.9.1621","volume":"145","author":"G Bodey","year":"1985","unstructured":"Bodey G, Jadeja L, Elting L (1985) Pseudomonas bacteremia. Arch Intern Med 145:1621\u20131629. https:\/\/doi.org\/10.1001\/archinte.145.9.1621","journal-title":"Arch Intern Med"},{"key":"4342_CR9","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1001\/archinte.1996.00440170139015","volume":"156","author":"F Vidal","year":"1996","unstructured":"Vidal F, Mensa J, Alemla M, Martinez J, Marco F, Casals C et al (1996) Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment. Arch Intern Med 156:2121\u20132126","journal-title":"Arch Intern Med"},{"key":"4342_CR10","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1086\/596709","volume":"48","author":"V Schechner","year":"2009","unstructured":"Schechner V, Nobre V, Kaye K, Leshno M, Giladi M, Rohneret P et al (2009) Gram-negative bacteremia upon hospital admission: when should Pseudomonas aeruginosa be suspected? Clin Infect Dis 48:580\u2013586. https:\/\/doi.org\/10.1086\/596709","journal-title":"Clin Infect Dis"},{"key":"4342_CR11","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s15010-011-0124-6","volume":"39","author":"E Joo","year":"2011","unstructured":"Joo E, Kang C, Ha E, Park P, Kang S, Wi Y et al (2011) Impact of inappropriate empiric antimicrobial therapy on outcome in Pseudomonas aeruginosa bacteremia: a stratified analysis according to sites of infection. Infection 39:309\u2013318. https:\/\/doi.org\/10.1007\/s15010-011-0124-6","journal-title":"Infection"},{"issue":"8","key":"4342_CR12","doi-asserted-by":"publisher","first-page":"3969","DOI":"10.1128\/AAC.02467-12","volume":"57","author":"A Hattemer","year":"2013","unstructured":"Hattemer A, Hauser A, Diaz M, Scheetz M, Shah N, Allen J et al (2013) Bacterial and clinical characteristics of health care- and community-acquired bloodstream infections due to Pseudomonas aeruginosa. Antimicrob Agents and Chemother 57(8):3969\u20133975. https:\/\/doi.org\/10.1128\/AAC.02467-12","journal-title":"Antimicrob Agents and Chemother"},{"issue":"1","key":"4342_CR13","doi-asserted-by":"publisher","first-page":"e01243","DOI":"10.1128\/AAC.01243-16","volume":"61","author":"D Buehrle","year":"2017","unstructured":"Buehrle D, Shields R, Clarke L, Potoski B, Clancy C, Nguyen M et al (2017) Carbapenem-resistant Pseudomonas aeruginosa bacteremia: risk factors for mortality and microbiologic treatment failure. Antimicrob Agents and Chemother 61(1):e01243-e1316. https:\/\/doi.org\/10.1128\/AAC.01243-16","journal-title":"Antimicrob Agents and Chemother"},{"issue":"3","key":"4342_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2019.06.002","volume":"95","author":"H Sader","year":"2019","unstructured":"Sader H, Castanheira M, Streit J, Flamm R (2019) Frequency of occurrence and antimicrobial susceptibility of bacteria isolated from patients hospitalized with bloodstream infections in United States medical centers (2015\u20132017). Diagn Microbiol Infect Dis 95(3):114850. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2019.06.002","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"3","key":"4342_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0091713","volume":"9","author":"D Anderson","year":"2014","unstructured":"Anderson D, Moehring R, Sloane R, Schmader K, Weber D, Fowler V et al (2014) Bloodstream infections in community hospitals in the 21st century: a multicenter cohort study. PLoS ONE 9(3):e91713. https:\/\/doi.org\/10.1371\/journal.pone.0091713","journal-title":"PLoS ONE"},{"key":"4342_CR16","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/jac\/dkw402","volume":"72","author":"S Battle","year":"2017","unstructured":"Battle S, Bookstaver B, Justo J, Kohn J, Albrecht H, Al-Hasan M (2017) Association between inappropriate empirical antimicrobial therapy and hospital length of stay in Gram-negative bloodstream infections: stratification by prognosis. J Antimicrob Chemother 72:299\u2013304. https:\/\/doi.org\/10.1093\/jac\/dkw402","journal-title":"J Antimicrob Chemother"},{"key":"4342_CR17","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","volume":"34","author":"A Kumar","year":"2006","unstructured":"Kumar A, Roberts D, Wood K, Light B, Parrillo J, Sharma S et al (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34:1589\u20131596. https:\/\/doi.org\/10.1097\/01.CCM.0000217961.75225.E9","journal-title":"Crit Care Med"},{"issue":"4","key":"4342_CR18","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1128\/AAC.49.4.1306-1311.2005","volume":"49","author":"S Micek","year":"2005","unstructured":"Micek S, Lloyd A, Ritchie D et al (2005) Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment. Antimicrob Agents Chemother 49(4):1306\u20131311. https:\/\/doi.org\/10.1128\/AAC.49.4.1306-1311.2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"4342_CR19","doi-asserted-by":"publisher","first-page":"3510","DOI":"10.1128\/AAC.00338-07","volume":"51","author":"T Lodise","year":"2007","unstructured":"Lodise T, Patel N, Kwa A, Graves J, Furuno J, Graffunder E et al (2007) Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection. Antimicrob Agents Chemother 51(10):3510\u20133515. https:\/\/doi.org\/10.1128\/AAC.00338-07","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"4342_CR20","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1093\/cid\/cit223","volume":"57","author":"C Pena","year":"2013","unstructured":"Pena C, Suarez C, Ocampo-Sosa A, Murillas J, Almirante B, Pomar V et al (2013) Effect of adequate single-drug vs combination antimicrobial therapy on mortality in Pseudomonas aeruginosa bloodstream infections: a post hoc analysis of a prospective cohort. Clin Infect Dis 57(2):208\u2013216. https:\/\/doi.org\/10.1093\/cid\/cit223","journal-title":"Clin Infect Dis"},{"issue":"8","key":"4342_CR21","doi-asserted-by":"publisher","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","volume":"147","author":"E Von Elm","year":"2007","unstructured":"Von Elm E, Altman D, Egger M, Pocock S, Gotzche P, Vandenbroucke J (2007) The strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med 147(8):573\u2013577","journal-title":"Ann Intern Med"},{"issue":"8","key":"4342_CR22","doi-asserted-by":"publisher","first-page":"585","DOI":"10.7326\/0003-4819-115-8-585","volume":"115","author":"J Chow","year":"1991","unstructured":"Chow J, Fine M, Shlaes D, Quinn P, Cooper D, Johnson M et al (1991) Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 115(8):585\u2013590. https:\/\/doi.org\/10.7326\/0003-4819-115-8-585","journal-title":"Ann Intern Med"},{"key":"4342_CR23","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s15010-019-01277-7","volume":"47","author":"S Battle","year":"2019","unstructured":"Battle S, Augustine M, Watson C, Bookstaver B, Kohn J, Owens W et al (2019) Derivation of a quick Pitt bacteremia score to predict mortality in patients with Gram-negative bloodstream infection. Infection 47:571\u2013578. https:\/\/doi.org\/10.1007\/s15010-019-01277-7","journal-title":"Infection"},{"issue":"9","key":"4342_CR24","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1093\/cid\/ciz528","volume":"70","author":"H Henderson","year":"2020","unstructured":"Henderson H, Luterbach C, Cober E, Richter S, Salata R, Kalayjian R et al (2020) The Pitt bacteremia score predicts mortality in nonbacteremic infections. Clin Infect Dis 70(9):1826\u20131833. https:\/\/doi.org\/10.1093\/cid\/ciz528","journal-title":"Clin Infect Dis"},{"key":"4342_CR25","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"A Magiorakos","year":"2012","unstructured":"Magiorakos A, Srinivasan A, Carey R, Carmeli Y, Falagas M, Giske C et al (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18:268\u2013281. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03570.x","journal-title":"Clin Microbiol Infect"},{"key":"4342_CR26","unstructured":"Centers for Disease Control. National Healthcare Safety Network (NHSN) Patient Safety Component Manual. 2020. https:\/\/www.cdc.gov\/nhsn\/pdfs\/pscmanual\/pcsmanual_current.pdf Accessed 12 December 2019."},{"issue":"5","key":"4342_CR27","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.jmii.2015.06.003","volume":"50","author":"C Lee","year":"2017","unstructured":"Lee C, Su T, Ye J, Hsu P, Kuo A, Chia J et al (2017) Risk factors and clinical significance of bacteremia caused by Pseudomonas aeruginosa resistant only to carbapenems. J Microbiol Immunol Infect 50(5):677\u2013683. https:\/\/doi.org\/10.1016\/j.jmii.2015.06.003","journal-title":"J Microbiol Immunol Infect"},{"key":"4342_CR28","unstructured":"QualityNet. Hospital inpatient specifications manuals section 2.1, severe sepsis and septic shock. Available at: https:\/\/www.qualitynet.org\/files\/5deda2b262faad001ffd7a46?filename=2-1_SEP_v5.8.pdf. Accessed 15 November 2020."},{"key":"4342_CR29","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa456","author":"A Pakyz","year":"2020","unstructured":"Pakyz A, Orndahl C, Johns A, Harless D, Morgan D, Bearman G et al (2020) Impact of the centers for Medicare and Medicaid Services Sepsis Core Measure on antibiotic use. Clin Infect Dis. https:\/\/doi.org\/10.1093\/cid\/ciaa456","journal-title":"Clin Infect Dis"},{"key":"4342_CR30","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1128\/JCM.00996-16","volume":"54","author":"S MacVane","year":"2016","unstructured":"MacVane S, Nolte F (2016) Benefits of adding a rapid PCR-based blood culture identification panel to an established antimicrobial stewardship program. J Clin Microbiol 54:2455\u20132463. https:\/\/doi.org\/10.1128\/JCM.00996-16","journal-title":"J Clin Microbiol"},{"issue":"7","key":"4342_CR31","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1093\/cid\/civ447","volume":"61","author":"R Banerjee","year":"2015","unstructured":"Banerjee R, Teng C, Cunningham S, Ihde S, Steckelberg J, Moriarty J et al (2015) Randomized trial of rapid multiplex polymerase chain reaction\u2013based blood culture identification and susceptibility testing. Clin Infect Dis 61(7):1071\u20131080. https:\/\/doi.org\/10.1093\/cid\/civ447","journal-title":"Clin Infect Dis"},{"key":"4342_CR32","doi-asserted-by":"publisher","unstructured":"Robinson E, Stilwell A, Attai A, Donohue L, Shah M, Hill B, et al. Implementation of a rapid phenotypic susceptibility platform for Gram-negative bloodstream infections with paired antimicrobial stewardship intervention: is the juice worth the squeeze? Clin Infect Dis. 2021;ciab126. https:\/\/doi.org\/10.1093\/cid\/ciab126.","DOI":"10.1093\/cid\/ciab126"},{"key":"4342_CR33","first-page":"62","volume":"109","author":"JA Korvick","year":"1991","unstructured":"Korvick JA, Marsh JW, Starzl TE, Yu VL (1991) Pseudomonas aeruginosa bacteremia in patients undergoing liver transplantation: an emerging problem. Surgery 109:62\u201368","journal-title":"Surgery"},{"issue":"7","key":"4342_CR34","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1128\/AAC.02365-12","volume":"57","author":"K Bauer","year":"2013","unstructured":"Bauer K, West J, O\u2019Brien J, Goff D (2013) Extended-infusion cefepime reduces mortality in patients with Pseudomonas aeruginosa infections. Antimicrob Agents Chemother 57(7):2907\u20132912. https:\/\/doi.org\/10.1128\/AAC.02365-12","journal-title":"Antimicrob Agents Chemother"},{"key":"4342_CR35","doi-asserted-by":"publisher","unstructured":"Hilf M, Yu VL, Sharp J, J Zuravleff, J Korvick, R Muder. Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. Am J Med. 1989;87(5):540\u20136, https:\/\/doi.org\/10.1016\/s0002-9343(89)80611-4.","DOI":"10.1016\/s0002-9343(89)80611-4"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-021-04342-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-021-04342-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-021-04342-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T14:22:19Z","timestamp":1641392539000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-021-04342-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,30]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["4342"],"URL":"https:\/\/doi.org\/10.1007\/s10096-021-04342-y","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,30]]},"assertion":[{"value":"30 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received an Institutional IRB exempt determination via HCA\u2019s CARRIE (Centralized Algorithms for Research Rules on IRB Exemption) system (Submission number 2019\u2013518).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The views expressed in this publication represent those of the author(s) and do not necessarily represent the official views of HCA Healthcare or any of its affiliated entities.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}